Internal Medicine, Hematology & Oncology · Lansing, MI
NPI
1528091980
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1215 E Michigan Ave
Lansing, MI, 48912
Phone (517) 364-2890
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
855 services
Medicare patients, 2024
364
Average age 72
Drug cost, 2024
$7.6M
3,218 prescriptions
Company payments, 2025
$72.27
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad Y Hamdan was code 99214 (office e&m - established), 540 times for 237 patients. In total Muhammad Y Hamdan billed 855 services in 14 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 540 | 237 | $67.54 | $36K |
| 99233 Hospital E&M - Subsequent | Facility | 80 | 27 | $90.45 | $7,236 |
| 99213 Office E&M - Established | Facility | 63 | 61 | $42.98 | $2,708 |
| 99205 Office E&M - New | Facility | 49 | 49 | $135.55 | $6,642 |
| 99223 Hospital E&M - Initial | Facility | 45 | 44 | $128.84 | $5,798 |
| 99205 Office E&M - New | Office | 26 | 26 | $167.46 | $4,354 |
| 38222 Other Organ Systems | Facility | 21 | 16 | $54.14 | $1,137 |
By year: 2022 $80K for 900 services; 2023 $59K for 778 services; 2024 $66K for 855 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad Y Hamdan prescribed most often to Medicare patients was Anastrozole, with 257 prescriptions and refills. In total Muhammad Y Hamdan wrote 3,218 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 257 | 491 | 58 | $9,002 |
| Ondansetron Hcl Generic | 193 | 193 | 109 | $1,669 |
| Eliquis Apixaban | 186 | 266 | 41 | $146K |
| Prochlorperazine Maleate Generic | 165 | 165 | 98 | $1,932 |
| Dexamethasone Generic | 119 | 121 | 34 | $1,423 |
| Prednisone Generic | 109 | 124 | 31 | $577 |
| Acyclovir Generic | 101 | 126 | 21 | $1,444 |
| Xarelto Rivaroxaban | 92 | 144 | 19 | $81K |
| Olanzapine Generic | 91 | 99 | 43 | $431 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 86 | 86 | 37 | $1,465 |
| Tamoxifen Citrate Generic | 85 | 125 | 17 | $1,738 |
| Jakafi Ruxolitinib Phosphate | 74 | 74 | Under 11 | $1.0M |
| Erleada Apalutamide | 72 | 72 | Under 11 | $1.0M |
| Letrozole Generic | 72 | 118 | 16 | $1,218 |
| Hydroxyurea Generic | 68 | 126 | 14 | $2,311 |
Brand drugs: - claims; generic drugs: 2,370 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad Y Hamdan $72.27 ($72.27 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novartis Pharmaceuticals Corporation with $44.63.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.